Cite
HARVARD Citation
Vermeire, S. et al. (n.d.). P379 Effect of upadacitinib on inflammatory markers and clinical outcomes in patients with Crohn's disease in the phase 3, U-EXCEL, U-EXCEED, and U-ENDURE studies. Journal of Crohn's and colitis. pp. i510-i513. [Online].